Key result
Routine 99mTc-MDP bone scans reveal incidental ATTR-CA uptake in ~4% of patients.
Why the study?
Early diagnosis of cardiac amyloidosis improves outcomes, and widely used 99mTc-MDP bone scintigraphy may offer a practical opportunity to identify suspected ATTR-CA through incidental cardiac uptake in resource-limited settings.
Does incidental cardiac uptake on routine 99mTc-MDP bone scans identify patients requiring further evaluation for ATTR-CA?
Observational (n=229)
No
Does incidental cardiac uptake on routine 99mTc-MDP bone scans identify patients requiring further evaluation for ATTR-CA?
Incidental cardiac uptake on routine 99mTc-MDP bone scans (Perugini score ≥ 2) can serve as an opportunistic flag to identify patients requiring further evaluation for ATTR-CA, particularly in resource-limited settings.
May flag suspected ATTR-CA via routine bone scans in resource-limited settings; leaves open prospective validation with confirmatory testing.
Background/Objectives: Early diagnosis of cardiac amyloidosis is crucial to improve patient outcomes. Although 99mTc-MDP is less sensitive than other bone-avid tracers for detecting ATTR-CA, it is widely used for routine bone imaging in this region. Incidental cardiac uptake on 99mTc-MDP bone scintigraphy may therefore offer a practical opportunity for identifying suspected ATTR-CA in resource-limited settings. To evaluate incidental cardiac uptake, warranting further evaluation for ATTR-CA on routine 99mTc-MDP bone scans as an incidental flag method for patients who require further evaluation and to propose a referral pathway in resource-limited settings. Methods: A retrospective review of 229 patients was performed. The assessment of myocardial uptake was performed using the Perugini visual score and H/CL ratio analysis. Patients’ medical records were reviewed, and available cardiac imaging reports were evaluated for further assessment of cardiac involvement. Results: Nine patients demonstrated a Perugini score = 2; of these, five underwent echocardiography, demonstrating abnormalities that may indicate amyloid involvement. No patient had confirmatory ATTR-CA testing, AL-CA exclusion testing, (CMR), biopsy, or amyloid typing. In patients without prior cardiac disease, echocardiographic abnormalities may potentially represent subclinical disease, such as cardiac amyloidosis, though this requires further confirmation. In patients with HTN or diabetes, the echocardiographic changes may be attributed to the underlying conditions. Echocardiographic characteristics suggestive, but not specific, for cardiac amyloidosis were observed in patients selected based on positive 99mTc-MDP uptake. Conclusions: Incidental cardiac uptake with a Perugini score ≥ 2 can highlight patients for ATTR-CA investigation. These results provide preliminary evidence that incidental 99mTc-MDP cardiac uptake can flag patients who require further evaluation for ATTR-CA and support the implementation of a referral pathway from local evaluation to a specialized center.
No takes yet. Share an insight, caveat, or question.
Darwesh et al. (2026) conducted an observational in Suspected ATTR-CA (n=229). 99mTc-MDP bone scintigraphy was evaluated on Incidental cardiac uptake with a Perugini score of 2 (95% CI 1.8-7.3). Incidental cardiac uptake with a Perugini score of 2 was identified in 3.9% of routine 99mTc-MDP bone scans, suggesting its potential utility as an opportunistic flag for suspected ATTR-CA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: